In 2013, there were only 17 clinical trials approved by the Drug Controller General of India. But, the number has slowly increased over the years, and by the year 2017, it reached to 97, which signifies a huge jump of more than 400% in a period of five years. The…
India is a country with a population of nearly 1.3 billion, comprising of a varied genetic background of all kinds of castes and creeds. With such a large population, India carries a huge burden of all kinds of diseases. Thus, it offers a large treatment-nave patient pool for the development…
Verily, the Life Sciences unit of Google parent Alphabet, has developed, with Google, a machine learning algorithm that can assess images for diabetic eye diseases. This automated screening tool checks for two leading causes of blindness seen in India – diabetic retinopathy and diabetic macular edema. The goal of detecting…
The 12th annual ISCR Conference was recently held in Delhi, where the theme was “Advancing the frontiers of health”. More than 500 clinical research professionals attended the conference to discuss how clinical trial reforms would build the future of Indian research and opportunities in India. The President of ISCR, Dr….